Grants per year
Personal profile
Research Interests
I have successfully conducted and published on prospective evaluations of patients with urologic cancers including prostate, bladder, kidney and testicular cancer and have found that the impact of cancer treatment goes beyond physical limitations associated with treatment. My recent research aims to understand the complexities associated with patient expectations. This includes balancing factors associated with patient satisfaction including patient personality, physician-patient relationship, information-processing style, and a comforting experience with the health care environment. Dr. Kundu’s research focuses include treatment of bladder cancer, kidney cancer, urinary tract cancer, prostate cancer, robotic prostatectomy, robotic nephrectomy, and cancer genetics.
My research focuses on strategies to diagnose and characterize bladder cancer, novel strategies to characterized prostate cancer aggressiveness, and prospectively studying quality of life outcomes in patients with urologic cancers.
My clinical interests include bladder cancer, continent urinary diversions for bladder cancer, multimodal therapy for advanced cancers including surgical therapy for bladder cancer, prostate cancer, kidney cancer, testis cancer, robotic surgery for bladder cancer, and testis cancer treatment.
Certifications and Licenses
| Urology |
Training Experience
| 2007 | Residency, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital) |
| 2009 | Fellowship, Memorial Sloan-Kettering Cancer Center |
Education/Academic qualification
MD, University of Illinois at Chicago
… → 2001
Research interests
- Bladder Cancer
- Cancer Genetics
- Kidney Cancer / Urinary Tract Cancer
- Prostate Cancer
- Robotic Nephrectomy
- Robotic Prostatectomy
Fingerprint Dive into the research topics where Shilajit D Kundu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 17 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants
Does an inflammatory bowel disease flare in men increase serum prostate-specific antigen?
Northwestern Memorial Hospital, Digestive Health Foundation
7/1/18 → 6/30/20
Project: Research project
Impact of Genetic Variants on Failure of Active Surveillance for ProstateCancer
NorthShore University HealthSystem Research Institute
3/1/15 → 7/31/20
Project: Research project
Prot# EN3348-303: A Phase 3, Randomized, Active-Controlled, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of EN3348(MCC) as Compared with Mitomycin C in the Intravesical Treatment of Subjects wit BCG Recurrent or Refractory Non-Muscle
Clinical Financial Services, LLC, Endo Pharmaceuticals Inc
2/2/12 → 2/2/15
Project: Research project
Utility-Assessment for Co-Morbidities in Prostate Cancer
University of Chicago, National Cancer Institute
7/2/10 → 6/30/12
Project: Research project
Research Output
Editorial Comment
Weiner, A. B. & Kundu, S. D., Feb 1 2020, In : The Journal of urology. 203, 2, p. 290-291 2 p.Research output: Contribution to journal › Comment/debate
Educational Material on Prostate Cancer Screening is Overly Complex and Fails to Meet Recommended Layperson Readability Guidelines
Rooney, M. K., Morgans, A. K., Chen, R. C., Golden, D. W., Meeks, J. J., Auffenberg, G., Kundu, S. D., Schaeffer, E. M., Hussain, M. H., Kalapurakal, J. A. & Sachdev, S., Jan 2020, In : Urology. 135, p. 1-3 3 p.Research output: Contribution to journal › Editorial
Technology-Based Psychosocial Intervention to Improve Quality of Life and Reduce Symptom Burden in Men with Advanced Prostate Cancer: Results from a Randomized Controlled Trial
Penedo, F. J., Fox, R. S., Oswald, L. B., Moreno, P. I., Boland, C. L., Estabrook, R., McGinty, H. L., Mohr, D. C., Begale, M. J., Dahn, J. R., Flury, S. C., Perry, K. T., Kundu, S. D. & Yanez, B., Jan 1 2020, (Accepted/In press) In : International Journal of Behavioral Medicine.Research output: Contribution to journal › Article
Comparing how anxiety is experienced between White and minority patients after local therapy for prostate cancer: A hypothesis-generating pilot study
Wong, V., Amarasekera, C., Victorson, D. E., Burns, J., Cella, D. & Kundu, S. D., Jan 1 2019, In : Canadian Urological Association Journal. 13, 1, p. E17-E18Research output: Contribution to journal › Short survey
Establishing a common metric for self-reported anxiety in patients with prostate cancer: Linking the Memorial Anxiety Scale for Prostate Cancer with PROMIS Anxiety
Victorson, D., Schalet, B. D., Kundu, S., Helfand, B. T., Novakovic, K., Penedo, F. & Cella, D., Sep 15 2019, In : Cancer. 125, 18, p. 3249-3258 10 p.Research output: Contribution to journal › Article